| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 1,214,000 | 1,099,000 | 1,216,000 | 1,317,000 | | Cost of Revenue | 885,000 | 819,000 | 860,000 | 939,000 | | | Gross Profit | 329,000 | 280,000 | 356,000 | 378,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 274,000 | 252,000 | 278,000 | 289,000 | | Non Recurring | 36,000 |
-
|
-
| 236,000 | | Others | 29,000 | 28,000 | 28,000 | 33,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,000) |
-
| 50,000 | (180,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | 2,000 | 1,000 | 3,000 | | Earnings Before Interest And Taxes | (19,000) | 2,000 | 51,000 | (177,000) | | Interest Expense | (6,000) | 4,000 | 2,000 | 3,000 | | Income Before Tax | (13,000) | (2,000) | 49,000 | (180,000) | | Income Tax Expense | (7,000) | (1,000) | 18,000 | (56,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,000) | (1,000) | 31,000 | (124,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 |
-
| (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,000) |
-
| 31,000 | (125,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,000) |
-
| $31,000 | ($125,000) |
|
0.02% Nasdaq 0.00%
Income Statement
